Rising Drug Costs Lead to PBM Scrutiny

Rising Drug Costs Lead to PBM Scrutiny

Pharmacy benefit managers (PBMs) have come under increased scrutiny as drug prices have begun to rise. As price spikes were identified, manufactures originally took the heat, but now are pointing the finger at PBMs who may also profit from higher prices.

Pin It on Pinterest